Lv1
10 积分 2025-01-11 加入
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
26天前
已完结
Based on multi-omics technology study the antibacterial mechanisms of pH-dependent N-GQDs beyond ROS
1个月前
已完结
Graphene and graphene-based nanocomposites: biomedical applications and biosafety
1个月前
已完结
Oral delivery of chitosan-bilirubin nanoparticles alleviates hepatic inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
1个月前
已完结
Nanotherapeutics for cardiovascular disease
1个月前
已完结
Critical Role of Nanomaterial Mechanical Properties in Drug Delivery, Nanovaccines and Beyond
1个月前
已完结
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism
1个月前
已完结
Fullerene nanoparticles for the treatment of ulcerative colitis
2个月前
已完结
Platelet adsorption and hemolytic properties of liquid crystal/composite polymers
3个月前
已完结
SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia/reperfusion injury by blocking JAK-STAT1 signalling pathways
4个月前
已完结
皖公网安备34019202002308
